The controlling shareholder of Dongyang Pharmaceutical (06887) plans to increase the company's shares by about HK$300 million to HK$600 million

Zhitong Finance App News, Dongyang Pharmaceutical (06887) issued an announcement. The board of directors was notified by Mr. Zhang Yushuai, the controlling shareholder and non-executive director of the company, that he intends to purchase the company's shares listed on the Hong Kong Stock Exchange Limited on the open market through it or through an entity controlled by it, thereby increasing the company's shares. Mr. Cheung plans to increase his share holdings worth between HK$30 billion and HK$600 million over the next six months through him or through the entities he controls. In the future, Mr. Zhang will increase the amount of his holdings through him or through his controlled entities as appropriate according to market conditions.

As of the date of this announcement, Mr. Zhang directly and indirectly through his controlled entities held a total of 294 million shares, accounting for approximately 51.11% of the issued shares (excluding treasury shares). The board of directors believes that the share increase plan reflects Mr. Zhang's firm confidence in the long-term development prospects of the Group and the value of the company.